keyword
https://read.qxmd.com/read/31938716/multicenter-cohort-of-patients-with-methicillin-resistant-staphylococcus-aureus-bacteremia-receiving-daptomycin-plus-ceftaroline-compared-with-other-mrsa-treatments
#41
JOURNAL ARTICLE
Erin K McCreary, Ravina Kullar, Matthew Geriak, Evan J Zasowski, Khulood Rizvi, Lucas T Schulz, Krista Ouellette, Logan Vasina, Fadi Haddad, Michael J Rybak, Marcus J Zervos, George Sakoulas, Warren E Rose
Background: Daptomycin and ceftaroline (DAP-CPT) have been used for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB), but have rarely been compared with other therapies. This study provides an exploratory analysis of patients placed on DAP-CPT vs standard of care (SOC) for MRSAB. Methods: This is a retrospective, matched cohort study MRSAB patients at 4 hospitals in the United States. Patients receiving DAP-CPT for ≥72 hours at any point in therapy were matched 2:1 when possible, 1:1 otherwise, to SOC, first by infection source, then age and renal function...
January 2020: Open Forum Infectious Diseases
https://read.qxmd.com/read/31932377/distinct-subpopulations-of-intravalvular-methicillin-resistant-staphylococcus-aureus-with-variable-susceptibility-to-daptomycin-in-tricuspid-valve-endocarditis
#42
JOURNAL ARTICLE
Christopher R Miller, Somrita Dey, Paula D Smolenski, Pushkar S Kulkarni, Jonathan M Monk, Richard Szubin, George Sakoulas, Andrew D Berti
We present a case of endocarditis wherein organisms cultured from different valve leaflets yielded different daptomycin susceptibility from each other, and from organisms obtained from peripheral blood culture. Genomic analyses showed mutations in mprF, purR and agrA. Pharmacokinetic simulations showed consistent activity of daptomycin+beta-lactam against all subpopulations. This represents an opportunity to understand S. aureus evolution and fitness in vivo on daptomycin therapy, and the role of beta-lactams to prevent selection of daptomycin resistant subpopulations...
January 13, 2020: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/31861446/reduced-production-of-bacterial-membrane-vesicles-predicts-mortality-in-st45-usa600-methicillin-resistant-staphylococcus-aureus-bacteremia
#43
JOURNAL ARTICLE
Somrita Dey, Smitha Gudipati, Christopher Giuliano, Marcus J Zervos, Jonathan M Monk, Richard Szubin, Sarah C J Jorgensen, George Sakoulas, Andrew D Berti
Immune biomarkers can stratify mortality risk in staphylococcal bacteremia. Microbial biomarkers may provide more consistent signals during early infection. We demonstrate that in ST45/USA600 bacteremia, bacterial membrane vesicle production in vitro predicts clinical mortality (773 vs. 116 RFU, survivors vs. decedents, p < 0.0001). Using a threshold of 301 relative fluorescence units (RFU), the sensitivity and specificity of the membrane vesicles to predict mortality are 78% and 90%, respectively. This platform is facile, scalable and can be integrated into clinical microbiology lab workflows...
December 18, 2019: Antibiotics
https://read.qxmd.com/read/31773134/cefazolin-and-ertapenem-salvage-therapy-rapidly-clears-persistent-methicillin-susceptible-staphylococcus-aureus-bacteremia
#44
JOURNAL ARTICLE
Erlinda R Ulloa, Kavindra V Singh, Matthew Geriak, Fadi Haddad, Barbara E Murray, Victor Nizet, George Sakoulas
Cefazolin and ertapenem combination therapy was used successfully to salvage 11 cases (6 endocarditis) of persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, including immediate clearance (≤24 hours) in 8 cases. While in vitro synergy was modest, cefazolin plus ertapenem exhibited synergistic action in a rat model of MSSA endocarditis. The combination of cefazolin and ertapenem provides potent in vivo activity against MSSA beyond what is predicted in vitro and warrants further clinical study in the treatment of refractory MSSA bacteremia and endocarditis...
September 12, 2020: Clinical Infectious Diseases
https://read.qxmd.com/read/31640978/reply-to-kalil-et-al-is-daptomycin-plus-ceftaroline-associated-with-better-clinical-outcomes-than-standard-of-care-monotherapy-for-staphylococcus-aureus-bacteremia
#45
JOURNAL ARTICLE
George Sakoulas, Matthew Geriak, Fadi Haddad, Warren Rose, Kerry LaPlante, Marcus Zervos, Ravina Kullar, Victor Nizet
No abstract text is available yet for this article.
November 2019: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/31367742/omadacycline-for-acute-bacterial-skin-and-skin-structure-infections
#46
RANDOMIZED CONTROLLED TRIAL
Fredrick M Abrahamian, George Sakoulas, Evan Tzanis, Amy Manley, Judith Steenbergen, Anita F Das, Paul B Eckburg, Paul C McGovern
BACKGROUND: Within the last decade, methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a frequent cause of purulent skin and soft tissue infections. New therapeutic options are being investigated for these infections. METHODS: We report an integrated analysis of 2 randomized, controlled studies involving omadacycline, a novel aminomethylcycline, and linezolid for the treatment of acute bacterial skin and skin structure infections (ABSSSI). Omadacycline in Acute Skin and Skin Structure Infections Study 1 (OASIS-1) initiated patients on intravenous omadacycline or linezolid, with the option to transition to an oral formulation after day 3...
August 1, 2019: Clinical Infectious Diseases
https://read.qxmd.com/read/31365924/il-1%C3%AE-and-il-10-host-responses-in-patients-with-staphylococcus-aureus-bacteremia-determined-by-antimicrobial-therapy
#47
JOURNAL ARTICLE
Cecilia F Volk, Sarah Burgdorf, Graham Edwardson, Victor Nizet, George Sakoulas, Warren E Rose
INTRODUCTION: Patient IL-1β and IL-10 responses early in the course of Staphylococcus aureus bacteremia (SaB) are associated with bacteremia duration and mortality. We hypothesized that these responses vary depending on choice of antimicrobial therapy, with particular interest in knowing whether the superior performance of -lactams may be linked to key cytokine signaling pathways. METHODS: Three medical centers included 59 patients with SaB (47 MRSA, 12 MSSA) from 2015-2017...
August 1, 2019: Clinical Infectious Diseases
https://read.qxmd.com/read/31353294/surprising-synergy-of-dual-translation-inhibition-vs-acinetobacter-baumannii-and-other-multidrug-resistant-bacterial-pathogens
#48
JOURNAL ARTICLE
Nicholas Dillon, Michelle Holland, Hannah Tsunemoto, Bryan Hancock, Ingrid Cornax, Joe Pogliano, George Sakoulas, Victor Nizet
BACKGROUND: Multidrug-resistant (MDR) Acinetobacter baumannii infections have high mortality rates and few treatment options. Synergistic drug combinations may improve clinical outcome and reduce further emergence of resistance in MDR pathogens. Here we show an unexpected potent synergy of two translation inhibitors against the pathogen: commonly prescribed macrolide antibiotic azithromycin (AZM), widely ignored as a treatment alternative for invasive Gram-negative pathogens, and minocycline, among the current standard-of-care agents used for A...
July 25, 2019: EBioMedicine
https://read.qxmd.com/read/31235559/treatment-of-multidrug-resistant-vancomycin-resistant-enterococcus-faecium-hardware-associated-vertebral-osteomyelitis-with-oritavancin-plus-ampicillin
#49
JOURNAL ARTICLE
Samira Dahesh, Brian Wong, Victor Nizet, George Sakoulas, Truc T Tran, Samuel L Aitken
Weekly oritavancin plus ampicillin continuous infusion combination therapy was used to successfully treat a deep spine vancomycin-resistant Enterococcus faecium infection associated with hardware. Checkerboard and time-kill assays confirmed synergy between these two antibiotics. Further synergies of oritavancin and ampicillin with rifampin or the endogenous human antimicrobial peptide cathelicidin LL-37 were demonstrated.
July 2019: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/30923801/avibactam-sensitizes-carbapenem-resistant-ndm-1-producing-klebsiella-pneumoniae-to-innate-immune-clearance
#50
JOURNAL ARTICLE
Erlinda R Ulloa, Nicholas Dillon, Hannah Tsunemoto, Joe Pogliano, George Sakoulas, Victor Nizet
Infections caused by New Delhi metallo-β-lactamase (NDM)-producing strains of multidrug-resistant Klebsiella pneumoniae are a global public health threat lacking reliable therapies. NDM is impervious to all existing β-lactamase inhibitor (BLI) drugs, including the non-β-lactam BLI avibactam (AVI). Though lacking direct activity against NDMs, AVI can interact with penicillin-binding protein 2 in a manner that may influence cell wall dynamics. We found that exposure of NDM-1-producing K. pneumoniae to AVI led to striking bactericidal interactions with human cathelicidin antimicrobial peptide LL-37, a frontline component of host innate immunity...
July 2, 2019: Journal of Infectious Diseases
https://read.qxmd.com/read/30923573/proton-pump-inhibitors-do-not-influence-clinical-outcomes-in-patients-with-staphylococcus-aureus-bacteremia
#51
JOURNAL ARTICLE
Aisling R Caffrey, Tristan T Timbrook, Syed Raza Ali, Victor Nizet, George Sakoulas
Background: Proton-pump inhibitors (PPIs) are commonly used in clinical practice for gastric acid suppression. However, these agents have also been associated with certain negative clinical outcomes. We evaluated the real-world effects of incident PPI use on clinical outcomes in patients with Staphylococcus aureus bacteremia. Methods: This retrospective cohort study included patients admitted to Veterans Affairs hospitals with positive S. aureus blood cultures collected between 2002 and 2013 that received appropriate antibiotics within 48 hours of culture collection...
2019: Therapeutic Advances in Gastroenterology
https://read.qxmd.com/read/30858203/clinical-data-on-daptomycin-plus-ceftaroline-versus-standard-of-care-monotherapy-in-the-treatment-of-methicillin-resistant-staphylococcus-aureus-bacteremia
#52
RANDOMIZED CONTROLLED TRIAL
Matthew Geriak, Fadi Haddad, Khulood Rizvi, Warren Rose, Ravina Kullar, Kerry LaPlante, Marie Yu, Logan Vasina, Krista Ouellette, Marcus Zervos, Victor Nizet, George Sakoulas
Vancomycin (VAN) and daptomycin (DAP) are approved as a monotherapy for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. A regimen of daptomycin plus ceftaroline (DAP+CPT) has shown promise in published case series of MRSA salvage therapy, but no comparative data exist to compare up-front DAP+CPT head-to-head therapy versus standard monotherapy as an initial treatment. In a pilot study, we evaluated 40 adult patients who were randomized to receive 6 to 8 mg/kg of body weight per day of DAP and 600 mg intravenous (i...
May 2019: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/30498561/the-draft-genome-sequence-of-nitrospira-lenta-strain-bs10-a-nitrite-oxidizing-bacterium-isolated-from-activated-sludge
#53
JOURNAL ARTICLE
Dimitra Sakoula, Boris Nowka, Eva Spieck, Holger Daims, Sebastian Lücker
The genus Nitrospira is considered to be the most widespread and abundant group of nitrite-oxidizing bacteria in many natural and man-made ecosystems. However, the ecophysiological versatility within this phylogenetic group remains highly understudied, mainly due to the lack of pure cultures and genomic data. To further expand our understanding of this biotechnologically important genus, we analyzed the high quality draft genome of " Nitrospira lenta " strain BS10, a sublineage II Nitrospira that was isolated from a municipal wastewater treatment plant in Hamburg, Germany...
2018: Standards in Genomic Sciences
https://read.qxmd.com/read/29986019/is-a-reported-penicillin-allergy-sufficient-grounds-to-forgo-the-multidimensional-antimicrobial-benefits-of-%C3%AE-lactam-antibiotics
#54
REVIEW
George Sakoulas, Matthew Geriak, Victor Nizet
The majority of patients with reported penicillin allergy are not allergic when tested or challenged. Penicillin allergy testing has been shown to significantly reduce annual healthcare expenditures. Data have emerged showing β-lactams have multidimensional antibacterial effects in vivo, far beyond what is appreciated in standard bacteriological susceptibility testing media. These include enhancing bacterial killing by the innate immune system. Supporting the clinical relevance of these secondary underappreciated effects are recent clinical and pharmacoeconomic analyses that show worse outcomes in patients with reported penicillin allergies who receive non-β-lactam antibiotics when compared to their non-penicillin-allergic counterparts...
January 1, 2019: Clinical Infectious Diseases
https://read.qxmd.com/read/29940362/evaluation-of-a-novel-quorum-quenching-strain-for-mbr-biofouling-mitigation
#55
JOURNAL ARTICLE
Ioannis D Kampouris, Panayotis D Karayannakidis, Dimitra C Banti, Dimitra Sakoula, Dimitris Konstantinidis, Minas Yiangou, Petros E Samaras
Membrane biofouling, due to Soluble Microbial Products (SMP) and Extracellular Polymeric Substances (EPS) deposition, results in reduction of the performance of Membrane Bioreactors (MBRs). However, recently, a new method of biofouling control has been developed, utilizing the interference of the bacterial inter- and intra-species' communication. Bacteria use Quorum Sensing (QS) to regulate the production of SMP and EPS. Therefore, disruption of Quorum Sensing (Quorum Quenching: QQ), by enzymes or microorganisms, may be a simple mean to control membrane biofouling...
October 15, 2018: Water Research
https://read.qxmd.com/read/29887846/the-staphylococcus-aureus-two-component-system-agrac-displays-four-distinct-genomic-arrangements-that-delineate-genomic-virulence-factor-signatures
#56
JOURNAL ARTICLE
Kumari S Choudhary, Nathan Mih, Jonathan Monk, Erol Kavvas, James T Yurkovich, George Sakoulas, Bernhard O Palsson
Two-component systems (TCSs) consist of a histidine kinase and a response regulator. Here, we evaluated the conservation of the AgrAC TCS among 149 completely sequenced Staphylococcus aureus strains. It is composed of four genes: agrBDCA . We found that: (i) AgrAC system ( agr ) was found in all but one of the 149 strains, (ii) the agr positive strains were further classified into four agr types based on AgrD protein sequences, (iii) the four agr types not only specified the chromosomal arrangement of the agr genes but also the sequence divergence of AgrC histidine kinase protein, which confers signal specificity, (iv) the sequence divergence was reflected in distinct structural properties especially in the transmembrane region and second extracellular binding domain, and (v) there was a strong correlation between the agr type and the virulence genomic profile of the organism...
2018: Frontiers in Microbiology
https://read.qxmd.com/read/29879195/characterization-of-genetic-changes-associated-with-daptomycin-nonsusceptibility-in-staphylococcus-aureus
#57
JOURNAL ARTICLE
Zhuo Ma, Erica Lasek-Nesselquist, Jackson Lu, Ryan Schneider, Riddhi Shah, George Oliva, Janice Pata, Kathleen McDonough, Manjunath P Pai, Warren E Rose, George Sakoulas, Meenakshi Malik
The extensive use of daptomycin (DAP) for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the last decade has led to the emergence of DAP non-susceptible (DNS) Staphylococcus aureus strains. A better understanding of the molecular changes underlying DAP-non-susceptibility is required for early diagnosis and intervention with alternate combination therapies. The phenotypic changes associated with DNS strains have been well established. However, the genotypic changes-especially the kinetics of expression of the genes responsible for DAP-non-susceptibility are not well understood...
2018: PloS One
https://read.qxmd.com/read/29807674/impact-of-cefazolin-co-administration-with-vancomycin-to-reduce-development-of-vancomycin-intermediate-staphylococcus-aureus
#58
JOURNAL ARTICLE
Nivedita B Singh, Juwon Yim, Seyedehameneh Jahanbakhsh, George Sakoulas, Michael J Rybak
OBJECTIVE: Development of antimicrobial resistance during monotherapy of complicated methicillin-resistant Staphylococcus aureus bacteremia is problematic due to cross-resistance between vancomycin (VAN) and daptomycin, the only approved agents for this condition. Our objective was to demonstrate that development of resistance under conditions of suboptimal VAN (200 mg q 12 h) exposure in S. aureus can be attenuated by addition of cefazolin (CFZ). METHODS: Two strains of S...
August 2018: Diagnostic Microbiology and Infectious Disease
https://read.qxmd.com/read/29651552/prevention-of-high-level-daptomycin-resistance-emergence-in-vitro-in-streptococcus-mitis-oralis-by-using-combination-antimicrobial-strategies
#59
JOURNAL ARTICLE
Brianne Zapata, Danya N Alvarez, Sabrina Farah, Cristina Garcia-de-la-Maria, Jose M Miro, George Sakoulas, Arnold S Bayer, Nagendra N Mishra
Among the viridans group streptococci, S. mitis-oralis strains are frequently resistant to multiple β-lactams and tolerant to vancomycin (VAN). This scenario has led to the proposed clinical use of newer agents, like daptomycin (DAP) for such S. mitis-oralis strains. However, recent recognition of the rapid and durable emergence of high-level DAP-resistance (DAP-R; DAP MICs > 256 µg/ml) induced by DAP exposures in vitro and in vivo has dampened enthusiasm for such approaches. In this study, we evaluated a broad range of DAP combination regimens in vitro for their capacity to prevent emergence of high-level DAP-R in a prototype S...
August 2018: Current Microbiology
https://read.qxmd.com/read/29533955/humanized-exposures-of-a-%C3%AE-lactam-%C3%AE-lactamase-inhibitor-tazobactam-versus-non-%C3%AE-lactam-%C3%AE-lactamase-inhibitor-avibactam-with-or-without-colistin-against-acinetobacter-baumannii-in-murine-thigh-and-lung-infection-models
#60
COMPARATIVE STUDY
Marguerite L Monogue, George Sakoulas, Victor Nizet, David P Nicolau
β-lactam-β-lactamase inhibitors (BLIs) have previously demonstrated antimicrobial activity against Acinetobacter baumannii (AB). Colistin retains the highest susceptibility rate against A. baumannii, and has demonstrated synergy with other antimicrobials, including β-lactam-BLIs. Therefore, we assessed the potential individual activity and synergistic combinations in vivo against carbapenem-susceptible (CS) and multidrug-resistant (MDR) A. baumannii isolates in neutropenic thigh and lung infection models...
2018: Pharmacology
keyword
keyword
160202
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.